Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

Walgreens’ new CEO unpacks how the chain will survive as a standalone business: #JPM24

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Walgreens’ new CEO Tim Wentworth insists the

January 11, 2024

FDA partially holds BioNTech’s Phase 3 anti-CTLA-4, company pauses enrollment

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 19, 2024

Millions were booted from Medicaid. The insurers that run it gained Medicaid revenue anyway.

Private Medicaid health plans lost millions of members in the past year as pandemic protections that prohibited states from dropping anyone from the government program

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.